ERBB2 and breast carcinoma: In human epidermal growth factor receptor (HER)-2 positive breast cancer cells, the combination of statins with anti-HER2 agents induces apoptosis by inhibiting AKT and extracellular signal-regulated kinases (ERK) phosphorylation.